RT
:
FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S. go.usa.gov/xvC75
martes, 7 de abril de 2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market | FDA
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market | FDA
RT
:
FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S. go.usa.gov/xvC75
RT
:
FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S. go.usa.gov/xvC75
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario